The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. …

2020年6月15日 · This review will provide an overview of DOAC s and act as a practical reference for clinicians to optimize DOAC use among common challenging scenarios. Topics addressed …

Although acquiring drugs at lower costs can provide a financial benefit to 340B hospitals, the complexities of the ambulatory pharmacy environment require thoughtful planning and …

The 340B Prime Vendor Program (PVP) is a contract awarded by HRSA, which is responsible for administering the 340B Drug Pricing Program. The Prime Vendor negotiates pricing discounts …

The 340B Program Handbook is designed as a practical guide for pharmacy leaders, hospital administrators, business managers, and pharmacy supply chain professionals implementing, …

2021年10月12日 · What are the benefits of participating in the 340B Program? biggest benefit is the savings on drug costs, which allows 318 grantees and subgrantees to expand their …

The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations …

2023年6月1日 · 美国340B药品定价计划。 20 世纪 90 年代，美国对符合一定条件的医疗机构实体门诊药品实施了 340B 药品定价计划（ 340B drug pricing program ，后简称“ 340B 计划”）， …

Medicare makes changes to the reimbursement and coverage of prescription drugs on an annual basis. The Health Resources and Services Administration (HRSA) administers the 340B Drug …

Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care …